Onconova Therapeutic
ONTX
Delayed Nasdaq - 08/18 09:58:40 pm
1.6USD
+2.56%
Upcoming events

- No events available -

Past Events
08/15/17 | 03:00pmInterim 2017 Earnings Call
08/15/17Interim 2017 Earnings Release
06/20/17 | 08:30pmBIO International Convention
05/17/17Annual General Meeting
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
5,55
6,37
-13%

0,85
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-23,7
-22,7
-4,6%

-26,9
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-19,7
-19,7
0,01%

-28,3
Net income
Million $
Released
Forecast
Spread
-19,7
-19,7
-0,07%

-26,2
EPS
 $
Released
Forecast
Spread
-4,44
-0,59
-651%

-3,05
Announcement Date03/27/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
0,32
0,22
51%

0,16
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-6,07
-6,83
11%

-6,75
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-2,58
-7,00
63%

-7,04
Net income
Million $
Released
Forecast
Spread
-2,58
-7,00
63%

-6,78
EPS
 $
Released
Forecast
Spread
-0,29
-0,72
60%

-0,73
Announcement Date08/15/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise